Philipp Haselmayer

TREM-1 ligand expression on platelets enhances neutrophil activation

Philipp Haselmayer, Ludger Große‐Hovest, Philipp von Landenberg et al. · Blood · 2007 · 208 citations · Full text

Ability of Bruton’s Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling

Andrew T. Bender, A.S. Gardberg, Albertina Pereira et al. · Molecular Pharmacology · 2017 · 176 citations

Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models

Philipp Haselmayer, Montserrat Camps, Lesley Liu‐Bujalski et al. · The Journal of Immunology · 2019 · 142 citations · Full text

Interaction of TLR2 and TLR4 Ligands with the N-terminal Domain of Gp96 Amplifies Innate and Adaptive Immune Responses

Tobias Warger, Nobert Hilf, Gerd Rechtsteiner et al. · Journal of Biological Chemistry · 2006 · 134 citations · Full text

Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease

Sebastian Torke, Roxanne Pretzsch, Darius Häusler et al. · Acta Neuropathologica · 2020 · 94 citations · Full text